IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled - PubMed (original) (raw)
Review
. 2000 May 15;19(21):2532-47.
doi: 10.1038/sj.onc.1203594.
Affiliations
- PMID: 10851052
- DOI: 10.1038/sj.onc.1203594
Review
IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled
E P Reddy et al. Oncogene. 2000.
Abstract
Hematopoiesis is the cumulative result of intricately regulated signal transduction cascades that are mediated by cytokines and their cognate receptors. Proper culmination of these diverse signaling pathways forms the basis for an orderly generation of different cell types and aberrations in these pathways is an underlying cause for diseases such as cancer. Over the past several years, downstream events initiated upon cytokine/growth factor stimulation have been a major focus of biomedical research. As a result, several key concepts have emerged allowing a better understanding of the complex signaling processes. A group of novel transcription factors, termed signal transducers and activators of transcription (STATs) appear to orchestrate the downstream events propagated by cytokine/growth factor interactions with their cognate receptors. Until recently, the JAK proteins were considered to be the tyrosine kinases, which dictated the levels of phosphorylation and activation of STAT proteins, forming the basis of the JAK-STAT model. However, over the past few years, increasing evidence has accumulated which indicates that at least some of the STAT protein activation may be mediated by members of the Src gene family following cytokine/growth factor stimulation. Studies have demonstrated that the Src-family of tyrosine kinases can phosphorylate and activate certain STAT proteins, in lieu of JAK kinases. In such a scenario, JAK kinases may be more crucial to phosphorylation of the cytokine/growth factor receptors and in the process create docking sites on the receptors for binding of SH2-containing proteins such as STATs, Src-kinases and other signaling intermediates. Tyrosine phosphorylation and activation of STAT proteins can be achieved either by JAKs or Src-kinases depending on the nature of STAT that is being activated. This forms the basis for the JAK-Src-STAT model proposed in this review. The concerted action of JAK kinases, members of the Src-kinase family and STAT proteins, leads to cell proliferation and cell survival, the end-point of the cytokine/growth factor stimulus. Oncogene (2000).
Similar articles
- JAKs, STATs and Src kinases in hematopoiesis.
Rane SG, Reddy EP. Rane SG, et al. Oncogene. 2002 May 13;21(21):3334-58. doi: 10.1038/sj.onc.1205398. Oncogene. 2002. PMID: 12032773 Review. - Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.
Chaturvedi P, Reddy MV, Reddy EP. Chaturvedi P, et al. Oncogene. 1998 Apr 2;16(13):1749-58. doi: 10.1038/sj.onc.1201972. Oncogene. 1998. PMID: 9582023 - The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T, Senga T, Naito Y, Matsuda S, Miyake Y, Yoshimura A, Hamaguchi M. Iwamoto T, et al. Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829. Oncogene. 2000. PMID: 11032030 - The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
Heim MH. Heim MH. J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):75-120. doi: 10.3109/10799899909036638. J Recept Signal Transduct Res. 1999. PMID: 10071751 Review.
Cited by
- Cytokine receptor splice variants in hematologic diseases.
Wang B, Mehta H. Wang B, et al. Cytokine. 2020 Mar;127:154919. doi: 10.1016/j.cyto.2019.154919. Epub 2019 Dec 6. Cytokine. 2020. PMID: 31816579 Free PMC article. Review. - STAT3 signaling in pulmonary arterial hypertension.
Paulin R, Meloche J, Bonnet S. Paulin R, et al. JAKSTAT. 2012 Oct 1;1(4):223-33. doi: 10.4161/jkst.22366. JAKSTAT. 2012. PMID: 24058777 Free PMC article. Review. - Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.
Izaguirre-Carbonell J, Christiansen L, Burns R, Schmitz J, Li C, Mokry RL, Bluemn T, Zheng Y, Shen J, Carlson KS, Rao S, Wang D, Zhu N. Izaguirre-Carbonell J, et al. Blood Adv. 2019 May 14;3(9):1499-1511. doi: 10.1182/bloodadvances.2018026054. Blood Adv. 2019. PMID: 31076406 Free PMC article. - Induction of the apoptosis, degranulation and IL-13 production of human basophils by butyrate and propionate via suppression of histone deacetylation.
Shi Y, Xu M, Pan S, Gao S, Ren J, Bai R, Li H, He C, Zhao S, Shi Z, Yu F, Xiang Z, Wang H. Shi Y, et al. Immunology. 2021 Oct;164(2):292-304. doi: 10.1111/imm.13370. Epub 2021 Jun 2. Immunology. 2021. PMID: 33999409 Free PMC article. - Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation.
Pasutto F, Sticht H, Hammersen G, Gillessen-Kaesbach G, Fitzpatrick DR, Nürnberg G, Brasch F, Schirmer-Zimmermann H, Tolmie JL, Chitayat D, Houge G, Fernández-Martínez L, Keating S, Mortier G, Hennekam RC, von der Wense A, Slavotinek A, Meinecke P, Bitoun P, Becker C, Nürnberg P, Reis A, Rauch A. Pasutto F, et al. Am J Hum Genet. 2007 Mar;80(3):550-60. doi: 10.1086/512203. Epub 2007 Jan 29. Am J Hum Genet. 2007. PMID: 17273977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous